PMEL and neoplasm: Engineered exosomes from tumor cells containing immunostimulatory CpG DNA or tumor antigens (TRP2, gp100, endogenous P1A tumor antigen and HSP70) stimulate DCs maturation and T cell immune responses (147, 148).